glp 1 and gout GLP-1 weight loss drugs could increase risk of osteoporosis gout, new research finds GLP-1a: Going beyond Traditional Use

They didn't quite patch together as well as, say, Sherrie Flick did in Reconsidering Happiness

In accordance with the target trial emulation framework, we first specified the protocol of a hypothetical randomized controlled trial (RCT) comparing the effects of initiating a GLP-1RA versus an SGLT2 inhibitor on the outcomes of AF/Aflutter and stroke among patients with T2D who have been receiving stable dose of levothyroxine

Avoid When Personal or family history of medullary thyroid cancer or MEN 2

Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity

Compounded medications are not evaluated or approved by the FDA for safety, efficacy or quality Healthcare leaders are closely monitoring the peptide regulatory approval pathways